Telix Pharma

Telix is a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR).

Industries

Biotechnology

Headquarters

North Melbourne, Australia

Stage

IPO

Employees

51-200

Links

Org chart

Christian Behrenbruch

CEO

Collapse

CEO, APAC

Group COO

Group CFO

Group CMO

Global CPO

Chief Scientist

Chief Business Development Officer & General Counsel

Melanie Farris

Chief Governance & Risk Officer, Group Company Secretary

Shintaro Nishimura

President, Telix Japan

Richard Valeix

President, EMEA

Tracey Brown

SVP, Global Clinical Operations

Kyahn Williamson

SVP, Investor Relations & Corporate Communications

Scott Law

SVP, Global Manufacturing Operations

Teams

View all

+12

Board of Directors

15 members

+11

Leadership Team

14 members

CEO and Executive Team

11 members

Discover similar companies

Microba Life Sciences

Brisbane, Australia · Post IPO Equity

Actinogen Medical

Sydney, Australia

Immutep

Sydney, Australia

Alterity Therapeutics

Parkville, Australia · Post IPO Equity

Mesoblast

Melbourne, Australia · Post IPO Equity

Benitec Biopharma

Balmain, Australia · Post IPO Equity

Guardant Health

Redwood City, United States · Venture

GenieUs Genomic

Darlinghurst, Australia

Scipher Medicine

Waltham, United States · Series D

Kazia Therapeutics

Sydney, Australia · Post IPO Equity

CSL

Broadmeadows, Australia

Novotech

Pyrmont, Australia · Debt Financing

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.